ALS Clinical Trials in Philadelphia

Showing 41-60 of 83 trials

Deep Phenotyping in Patients With ALS

NCT02819765

This study aims to establish a biorepository and phenotyping database to investigate longitudinal changes in ALS subjects. Blood, including DNA and RNA, cerebrospinal fluid (CSF) and electrophysiologic measures will be collected every 6 months over 1 and a half years. The database and specimen repository will be made available to ALS researchers on a merit basis.

ALSMotor Neuron Disease

Barrow Neurological Institute32 participantsStarted Feb 2017

Phoenix, Arizona, United States • Grand Rapids, Michigan, United States • New York, New York, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

NCT00931944

This is an open-label, multi-center study designed to extend the evaluation of the safety, tolerability, and clinical effects of oral administration of KNS-760704 in patients with ALS.

Amyotrophic Lateral Sclerosis

Knopp Biosciences74 participantsStarted Jul 2009

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +16 more locations

Deep Phenotyping in Patients With ALS

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

ALS Trials in Other Cities

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

FES Assisted Cycling in Children With CP

Cognitive Impairement In Frontotemporal Dementia

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products

Balance and Posture in Adults With Cerebral Palsy

Design of an Affordable Gym for Post Stroke Rehabilitation

Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Answer ALS: Individualized Initiative for ALS Discovery

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Other Conditions in Philadelphia